- Forums
- ASX - By Stock
- 1AD
- Ann: SYNThesis BioVentures MoU for cellular immunotherapies
Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-77
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.05M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 718710 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 560699 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 718710 | 0.017 |
6 | 332618 | 0.016 |
3 | 494995 | 0.015 |
1 | 150000 | 0.014 |
1 | 70000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 560699 | 4 |
0.020 | 227023 | 3 |
0.024 | 6250 | 1 |
0.025 | 5906 | 1 |
0.027 | 307269 | 1 |
Last trade - 16.13pm 15/11/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online